PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-127

  1. 345 Posts.
    lightbulb Created with Sketch. 93
    yep, you are right. The best laid plans have come undone. Good point. I’ve been disappointed with the balance sheet since situation and not worked through that timeline objectively.

    Well let’s see what the regulators say and where the “2025 cash runway” and/or our super consultant can take us.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.